Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2026)

Silence Therapeutics has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $127000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $127000.0, down 96.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $127000.0 (down 96.49% YoY), and the FY2025 annual result was $127000.0, down 64.33% from the prior year.
• Other Non-Current Assets came in at $127000.0 for Q1 2026 at Silence Therapeutics, roughly flat from $127000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.9 million in Q2 2025 to a low of $127000.0 in Q4 2025.
• The 4-year median for Other Non-Current Assets is $399000.0 (2025), against an average of $1.7 million.
• Across the five-year window, Other Non-Current Assets plunged 64.33% in 2025 and plunged 96.49% in 2026, its largest moves.
• Silence Therapeutics' Other Non-Current Assets stood at $3.2 million in 2023, then sank by 88.88% to $356000.0 in 2024, then slumped by 64.33% to $127000.0 in 2025, then changed by 0.0% to $127000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $127000.0 (Q1 2026), $127000.0 (Q4 2025), and $399000.0 (Q3 2025), per Business Quant data.